RETA Message Board Post 9886298 | Reata Pharmaceuticals...
home / stock / reta / reta message board
ramo1989
(investorshub)
Posted on: Feb/24/2023 14:17:46
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171287667
Emphasis of a matter in EY audit opinion.
News, Short Squeeze, Breakout and More Instantly...
Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
Market:
Reata Pharmaceuticals Inc. Website:
-
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
-
Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023
-
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS ® (omaveloxolone), the first and only FDA approved treatment for Friedreich’s ataxia in the U.S. CAMBRIDGE, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (N...